The Science of Saving Vision: David Esposito, CEO of ONL Therapeutics | Ep. 48
Автор: Industry Ignited
Загружено: 2025-12-14
Просмотров: 5
In this episode of Industry Ignited, Dr. Leeanne Aguilar speaks with David Esposito, Chief Executive Officer of ONL Therapeutics, a decorated combat veteran and seasoned healthcare executive who has successfully built and scaled multiple life science companies. David shares how leadership forged on the battlefield now guides his work at the forefront of biotech innovation, where ONL Therapeutics is pioneering a first-in-class approach to preserving vision by preventing Fas-mediated retinal cell death—the root cause of many blinding conditions. He discusses the realities of leading high-risk clinical-stage companies, the discipline required to navigate long clinical trials, and the importance of humility, communication, and purpose when outcomes directly impact patients’ quality of life. Through ONL’s breakthrough therapeutic candidate, ONL1204, David illustrates how courage, compassion, and scientific rigor must work together to advance medicine, move science forward, and give patients a real chance to preserve their sight.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
